NR1I3 and Obesity: In this review, we briefly summarize the roles of PPARs, CAR and LXRs and their ligands in the treatment of metabolic diseases, obesity and atherosclerosis, and discuss the cross-talk of PPARs-CAR and PPARs-LXRs in lipid metabolism regulation.